Gary K Johnson, MD | |
118 S 12th St, Mount Vernon, WA 98274-4036 | |
(360) 336-2178 | |
(360) 336-1995 |
Full Name | Gary K Johnson |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 50 Years |
Location | 118 S 12th St, Mount Vernon, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437129186 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Skagit Valley Hospital | Mount vernon, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Public Hospital Dist No 1 Skagit | 6800793522 | 248 |
News Archive
A novel gene therapy technique is safe and may be effective at staving off worsening symptoms of Parkinson's disease, according to the first scientific review of a dozen patients who have received the treatment over the last three years.
AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.
Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.
Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver.
› Verified 3 days ago
Entity Name | Proliance Surgeons Inc Ps |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023170313 PECOS PAC ID: 8527972900 Enrollment ID: O20031119000128 |
News Archive
A novel gene therapy technique is safe and may be effective at staving off worsening symptoms of Parkinson's disease, according to the first scientific review of a dozen patients who have received the treatment over the last three years.
AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.
Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.
Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver.
› Verified 3 days ago
Entity Name | Public Hospital Dist No 1 Skagit |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023332749 PECOS PAC ID: 6800793522 Enrollment ID: O20040309001059 |
News Archive
A novel gene therapy technique is safe and may be effective at staving off worsening symptoms of Parkinson's disease, according to the first scientific review of a dozen patients who have received the treatment over the last three years.
AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.
Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.
Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Gary K Johnson, MD 1400 E Kincaid St, Mount Vernon, WA 98274-4127 Ph: (360) 336-2178 | Gary K Johnson, MD 118 S 12th St, Mount Vernon, WA 98274-4036 Ph: (360) 336-2178 |
News Archive
A novel gene therapy technique is safe and may be effective at staving off worsening symptoms of Parkinson's disease, according to the first scientific review of a dozen patients who have received the treatment over the last three years.
AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.
Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.
Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver.
› Verified 3 days ago
James R Gross, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 118 S 12th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1995 | |
Dr. Christopher Ray England, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 118 S 12th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1995 | |
Dr. Michael Bryan Mullen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 118 S 12th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1995 | |
Gary L Brown, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 118 S 12th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1995 | |
Dr. Jonathan R Grant, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 111 S 13th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-1674 | |
Dr. Anna Jane Knisely, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 S 13th St, Mount Vernon, WA 98274 Phone: 360-336-2178 Fax: 360-336-2642 |